RNA therapeutics is arguably at the forefront of the treatment for a number of complex medical disorders. From Oncological implications to cardiovascular disease, the investigation into the mechanisms which inhibit specific gene expression could provide the key to the eradication of a number of diseases. SMi’s highly respected RNA Therapeutics conference returns to London to discuss the latest findings and research in the field of RNAi technologies and the delivery mechanisms by which these therapies are administered to their target tissues.

The conference will showcase presentations from distinguished speakers with the latest insights into some of the most promising technologies in RNAi development and delivery, as well as addressing some of the current IP and regulatory challenges faced in the development and protection of these technologies.

KEY REASONS TO ATTEND

• Discover how nano-diamond vectors may be an alternative method for RNAi delivery
• Determine how to successfully target transcription factors and the advantage of doing this
• Identify new and potentially successful ways of delivering RNAi therapeutic proteins to target tissues using natural exosome nano-vehicles
• Discuss oligonucleotide purification methods and their future prospects
• Network with industry leaders in the field of RNA Therapeutics

For further information click here